Cabaletta Bio, Inc.
CABA
$3.59
-$0.05-1.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.42M | 6.76M | 8.27M | 8.12M | 8.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.61M | 46.59M | 45.91M | 37.14M | 33.79M |
| Operating Income | -42.61M | -46.59M | -45.91M | -37.14M | -33.79M |
| Income Before Tax | -41.92M | -44.87M | -45.13M | -35.94M | -32.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -41.92M | -44.87M | -45.13M | -35.94M | -32.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.92M | -44.87M | -45.13M | -35.94M | -32.59M |
| EBIT | -42.61M | -46.59M | -45.91M | -37.14M | -33.79M |
| EBITDA | -42.26M | -46.24M | -45.44M | -36.65M | -33.32M |
| EPS Basic | -0.40 | -0.44 | -0.73 | -0.71 | -0.65 |
| Normalized Basic EPS | -0.25 | -0.27 | -0.46 | -0.44 | -0.41 |
| EPS Diluted | -0.40 | -0.44 | -0.73 | -0.71 | -0.65 |
| Normalized Diluted EPS | -0.25 | -0.27 | -0.46 | -0.44 | -0.41 |
| Average Basic Shares Outstanding | 104.80M | 102.26M | 61.88M | 50.74M | 50.13M |
| Average Diluted Shares Outstanding | 104.80M | 102.26M | 61.88M | 50.74M | 50.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |